BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17600040)

  • 1. Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women.
    Westerhout CM; Lauer MS; James S; Fu Y; Wallentin L; Armstrong PW;
    Eur Heart J; 2007 Sep; 28(17):2064-9. PubMed ID: 17600040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers.
    Westerhout CM; Fu Y; Lauer MS; James S; Armstrong PW; Al-Hattab E; Califf RM; Simoons ML; Wallentin L; Boersma E;
    J Am Coll Cardiol; 2006 Sep; 48(5):939-47. PubMed ID: 16949483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy).
    James SK; Lindahl B; Timmer JR; Ottervanger JP; Siegbahn A; Stridsberg M; Armstrong P; Califf R; Wallentin L; Simoons ML
    Am J Cardiol; 2006 Jan; 97(2):167-72. PubMed ID: 16442356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
    Ang DS; Kong CF; Kao MP; Struthers AD
    Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.
    Windhausen F; Hirsch A; Sanders GT; Cornel J; Fischer J; van Straalen JP; Tijssen JG; Verheugt FW; de Winter RJ;
    Am Heart J; 2007 Apr; 153(4):485-92. PubMed ID: 17383283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short- and long-term outcomes of patients with electrocardiographic left ventricular hypertrophy after fibrinolysis for acute myocardial infarction.
    Georgescu A; Fu Y; Yau C; Hassan Q; Luchansky J; Armstrong PW; Wagner G; Van de Werf F; Goodman SG;
    Am J Cardiol; 2005 Oct; 96(8):1050-2. PubMed ID: 16214436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
    Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW
    J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
    James SK; Lindahl B; Siegbahn A; Stridsberg M; Venge P; Armstrong P; Barnathan ES; Califf R; Topol EJ; Simoons ML; Wallentin L
    Circulation; 2003 Jul; 108(3):275-81. PubMed ID: 12847065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary coronary intervention in diabetic octogenarians with acute ST elevation myocardial infarction.
    Sosnowski C; Janeczko-Sosnowska E; Woźniak J; Jasiński B; Dabrowski R; Sumiński A; Wiernikowski A; Ostrzycki A; Szwed H; Ruzyłło W
    Kardiol Pol; 2007 Oct; 65(10):1181-6; discussion 1187-9. PubMed ID: 17979046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in the use of stress testing and outcomes in patients with non-ST-elevation acute coronary syndromes: insights from GUSTO IIb.
    Mehta RH; Rao SV; Ohman EM; Bates ER; Marcucci G; Zhang M; Pieper KS; Armstrong PW; White HD; Van de Werf F; Califf RM; Granger CB
    Eur Heart J; 2008 Apr; 29(7):880-7. PubMed ID: 18334473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transition from CK-MB to troponin did not improve the 1 year mortality of non-ST elevation acute coronary syndromes.
    Novack V; Jotkowitz AB; Cutlip D; Amit G; Liebermann N; Porath A
    Postgrad Med J; 2008 Jan; 84(987):50-5. PubMed ID: 18230752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary treatment and adherence to guidelines in women and men with acute coronary syndromes.
    Moriel M; Tzivoni D; Behar S; Zahger D; Hod H; Hasdai D; Sandach A; Gottlieb S
    Int J Cardiol; 2008 Dec; 131(1):97-104. PubMed ID: 18222551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with non-ST-elevation myocardial infarction and without chest pain are treated less aggressively and experience higher in-hospital mortality.
    Zdzienicka J; Siudak Z; Zawiślak B; Dziewierz A; Rakowski T; Dubiel J; Dudek D
    Kardiol Pol; 2007 Jul; 65(7):769-75; discussion 776-7. PubMed ID: 17694458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive prognostic value of NT-proBNP over TIMI risk score in intermediate-risk patients with acute coronary syndrome.
    Eren NK; Ertaş F; Yüksek U; Cakir C; Nazli C; Köseoğlu M; Ergene O
    Turk Kardiyol Dern Ars; 2009 Jan; 37(1):1-8. PubMed ID: 19225247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy.
    James SK; Lindbäck J; Tilly J; Siegbahn A; Venge P; Armstrong P; Califf R; Simoons ML; Wallentin L; Lindahl B
    J Am Coll Cardiol; 2006 Sep; 48(6):1146-54. PubMed ID: 16978997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial.
    Scirica BM; Morrow DA; Budaj A; Dalby AJ; Mohanavelu S; Qin J; Aroesty J; Hedgepeth CM; Stone PH; Braunwald E
    J Am Coll Cardiol; 2009 Apr; 53(16):1411-21. PubMed ID: 19371824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
    Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ;
    Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between red blood cell distribution width and outcomes at six months in patients with acute coronary syndromes.
    Nabais S; Losa N; Gaspar A; Rocha S; Costa J; Azevedo P; Basto L; Pereira MA; Correia A
    Rev Port Cardiol; 2009 Sep; 28(9):905-24. PubMed ID: 19998803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.